Screener
Phathom Pharmaceuticals, Inc. PHAT Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue, net | $74,274 | $39,503 | $132,575 | $68,023 |
| Cost of revenue | 15,096 | 5,038 | 27,091 | 8,762 |
| Gross profit | 59,178 | 34,465 | 105,484 | 59,261 |
| Operating expenses: | ||||
| Research and development | 7,813 | 9,076 | 15,585 | 18,260 |
| Selling, general and administrative | 55,330 | 85,313 | 109,341 | 179,787 |
| Total operating expenses | 63,143 | 94,389 | 124,926 | 198,047 |
| Loss from operations | (3,965) | (59,924) | (19,442) | (138,786) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s total revenue?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total revenue of $74.27M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s total revenue changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total revenue increased by 88.0% year-over-year, from $39.5M to $74.27M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Phathom Pharmaceuticals, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude